This inventor holds 1 USPTO granted patent. Top assignee: Tetranov Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Yang Geng: Innovator in Pharmaceutical Composition
Introduction
Yang Geng is a notable inventor based in Zhengzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurodegenerative diseases.
Latest Patents
Yang Geng holds a patent for a [1,3]thiazin-2-amine compound, which is directed towards applications and pharmaceutical compositions. This invention is particularly relevant in the context of BACE inhibitors. The compound, represented by formula (I) or its pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug, demonstrates a strong inhibitory effect on BACE. It has potential applications in preparing medicaments for treating neurodegenerative diseases, such as Alzheimer's disease. He has 1 patent to his name.
Career Highlights
Yang Geng is associated with Tetranov Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for complex medical conditions.
Collaborations
Yang collaborates with talented individuals in his field, including Yusheng Wu and Apeng Liang. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Yang Geng is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to neurodegenerative disease treatment. His work exemplifies the importance of research and development in creating effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile